secukinumab · Medicine question

For how long after secukinumab treatment should women of childbearing potential continue effective contraception?

Name: For how long after secukinumab treatment should women of childbearing potential continue effective contraception?
Published: 2026-11-08T02:00:54.694Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Women of childbearing potential should use effective contraception during secukinumab treatment and for at least 20 weeks after treatment.

Sources for this answer

Cosentyx 150mg and 300mg solution for injection in pre-filled syringe and pre-filled penNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 29Document updated 19 August 2025

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about secukinumab